Stock BRTX BIORESTORATIVE THERAPIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus BioRestorative Therapies, Inc.

Equities

BRTX

US0906556065

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.25 USD +1.63% Intraday chart for BioRestorative Therapies, Inc. -8.76% -28.16%
Apr. 16 BioRestorative Therapies Shares Rise 17% After FDA Clears Phase 2 Study Protocol Amendment DJ
Apr. 16 BioRestorative Therapies Says US FDA Clears Amended Protocol for Phase 2 Cell Therapy Trial MT

Evolution of the average Target Price on BioRestorative Therapies, Inc.

Price target over the last 5 years

History of analyst recommendation changes

61de8a8c06.CT3uqb1kTKWxTm-s18t396RLIlTwkkpcTCIYWGdAUFM.ZQ--7tQDNd3wKlz1ma4hovIpWgKy-QJsImBibioiHQtbBKub9S4mk9AoDA~4b09349a132a653cf69c81e8667c37ec

Analyst Recommendations on BioRestorative Therapies, Inc.

Roth Capital Initiates BioRestorative Therapies at Buy Rating With $15 Price Target MT
Maxim Starts BioRestorative Therapies at Buy With $6 Price Target MT
Roth Capital Starts BioRestorative Therapies at Buy With $37 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.25 USD
Average target price
10.5 USD
Spread / Average Target
+740.00%
High Price Target
15 USD
Spread / Highest target
+1,100.00%
Low Price Target
6 USD
Spread / Lowest Target
+380.00%

Consensus detail

Consensus revision (last 18 months)

Analysts covering BioRestorative Therapies, Inc.

Roth Capital Partners
Maxim

Ratings for BioRestorative Therapies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BRTX Stock
  4. Consensus BioRestorative Therapies, Inc.